These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15724137)

  • 1. Coronary artery disease. The other half of the heaven.
    Milan E
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):72-80. PubMed ID: 15724137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of myocardial perfusion imaging in special populations: women, diabetics, and heart failure.
    Mieres JH; Rosman DR; Shaw LJ
    Semin Nucl Med; 2005 Jan; 35(1):52-61. PubMed ID: 15645394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of normal exercise 99mTc-sestamibi myocardial tomography in patients with angiographic coronary artery disease.
    Yang MF; Dou KF; Liu XJ; Yang YJ; He ZX
    Nucl Med Commun; 2006 Apr; 27(4):333-8. PubMed ID: 16531918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of multidetector computed tomography after mildly abnormal myocardial perfusion stress testing in a large single-specialty cardiology practice.
    Hines JL; Danciu SC; Shah M; Borg MJ; Biga C
    J Cardiovasc Comput Tomogr; 2008 Nov; 2(6):372-8. PubMed ID: 19083980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Diercks DB; Owen KP; Kontos MC; Blomkalns A; Chen AY; Miller C; Wiviott S; Peterson ED
    Am Heart J; 2010 Jul; 160(1):80-87.e3. PubMed ID: 20598976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial perfusion in women with systemic lupus erythomatosus and no symptoms of coronary artery disease.
    Czuszyńska Z; Romanowicz G
    Nucl Med Rev Cent East Eur; 2004; 7(2):171-4. PubMed ID: 15968605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in detecting coronary artery disease with dipyridamole stress myocardial perfusion imaging using 99m-Tc sestamibi gated SPECT.
    Majstorov V; Pop Gjorceva D; Vaskova O; Vavlukis M; Peovska I; Maksimović J
    Prilozi; 2005 Aug; 26(1):93-102. PubMed ID: 16118618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging.
    Leslie WD; Tully SA; Yogendran MS; Ward LM; Nour KA; Metge CJ
    J Nucl Med; 2005 Feb; 46(2):204-11. PubMed ID: 15695777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related imaging issues in assessment of coronary artery disease by nuclear techniques.
    Grover-McKay M
    Am J Card Imaging; 1996 Jan; 10(1):54-64. PubMed ID: 8680134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary CT angiography: asking the right questions.
    Cole JH
    J Cardiovasc Comput Tomogr; 2008 Nov; 2(6):379-81. PubMed ID: 19083981
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
    Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
    Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.
    Schinkel AF; Elhendy A; Bax JJ; van Domburg RT; Huurman A; Valkema R; Biagini E; Rizzello V; Feringa HH; Krenning EP; Simoons ML; Poldermans D
    Am J Cardiol; 2006 Jan; 97(1):1-6. PubMed ID: 16377272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of coronary artery disease in women.
    Travin MI; Johnson LL
    Curr Opin Cardiol; 1997 Nov; 12(6):587-94. PubMed ID: 9429832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WOMEN study: what is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study design.
    Mieres JH; Shaw LJ; Hendel RC; Heller GV
    J Nucl Cardiol; 2009; 16(1):105-12. PubMed ID: 19152135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nuclear imaging after coronary revascularization.
    Adams GL; Ambati SR; Adams JM; Borges-Neto S
    J Nucl Cardiol; 2006; 13(2):163-9. PubMed ID: 16580950
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects.
    Johnson NP; Gould KL
    J Nucl Med; 2005 Sep; 46(9):1427-37. PubMed ID: 16157524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
    Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.